Genetic Polymorphisms Associated with Retinal Vein Occlusion: A Greek Case-control Study and Meta-analysis

REFERENCES

• Rogers S, McIntosh RL, Cheung N, et al. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology 2010;117:313–319
   PubMed Web of Science ®Google Scholar
• Klein R, Moss SE, Meuer SM, et al. The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study. Arch Ophthalmol 2008;126:513–518
   PubMed Web of Science ®Google Scholar
• Hayreh SS, Podhajsky PA, Zimmerman MB. Branch retinal artery occlusion: natural history of visual outcome. Ophthalmology 2009;116:1188–1194
   PubMed Web of Science ®Google Scholar
• Hayreh SS, Podhajsky PA, Zimmerman MB. Natural history of visual outcome in central retinal vein occlusion. Ophthalmology 2011;118:119–133
   PubMed Web of Science ®Google Scholar
• Rath EZ, Frank RN, Shin DH, et al. Risk factors for retinal vein occlusions. A case-control study. Ophthalmology 1992;99:509–514
   PubMed Web of Science ®Google Scholar
• O’Mahoney PR, Wong DT, Ray JG. Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol 2008;126:692–699
   PubMed Web of Science ®Google Scholar
• Wong TY, Larsen EK, Klein R, et al. Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities & Cardiovascular Health studies. Ophthalmology 2005;112:540–547
   PubMed Web of Science ®Google Scholar
• Janssen MC, den Heijer M, Cruysberg JR, et al. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost 2005;93:1021–1026
   PubMed Web of Science ®Google Scholar
• Marcucci R, Bertini L, Liotta AA, et al. Activated protein C resistance is a risk factor for central retinal vein occlusion. Ann Ital Med Int 2000;15:195–198
   Google Scholar
• Gori AM, Marcucci R, Fatini C, et al. Impaired fibrinolysis in retinal vein occlusion: a role for genetic determinants of PAI-1 levels. Thromb Haemost 2004;92:54–60
   PubMed Web of Science ®Google Scholar
• Hansen L, Kristensen HL, Bek T, et al. Markers of thrombophilia in retinal vein thrombosis. Acta Ophthalmol Scand 2000;78:523–526
   PubMedGoogle Scholar
• Greiner K, Hafner G, Dick B, et al. Retinal vascular occlusion and deficiencies in the protein C pathway. Am J Ophthalmol 1999;128:69–74
   PubMed Web of Science ®Google Scholar
• Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:698–703
   Google Scholar
• Salomon O, Moisseiev J, Rosenberg N, et al. Analysis of genetic polymorphisms related to thrombosis and other risk factors in patients with retinal vein occlusion. Blood Coagul Fibrinolysis 1998;9:617–622
   PubMed Web of Science ®Google Scholar
• Balta G, Altay C, Gurgey A. PAI-1 gene 4G/5G genotype: a risk factor for thrombosis in vessels of internal organs. Am J Hematol 2002;71:89–93
   PubMed Web of Science ®Google Scholar
• Gohil R, Peck G, Sharma P. The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls. Thromb Haemost 2009;102:360–370
   PubMed Web of Science ®Google Scholar
• Hayreh SS. Classification of central retinal vein occlusion. Ophthalmology 1983;90:458–474
   PubMed Web of Science ®Google Scholar
• Dahlbck B. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis. J Intern Med Suppl 1997;740:1–8
   Google Scholar
• Deloughery TG, Evans A, Sadeghi A, et al. Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease. Circulation 1996;94:3074–3078
   PubMed Web of Science ®Google Scholar
• Weisberg I, Tran P, Christensen B, et al. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998;64:169–172
   PubMed Web of Science ®Google Scholar
• Bernardi F, Faioni EM, Castoldi E, et al. A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype. Blood 1997;90:1552–1557
   PubMed Web of Science ®Google Scholar
• Ariëns RA, Philippou H, Nagaswami C, et al. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood 2000;96:988–995
   PubMed Web of Science ®Google Scholar
• Brown ET, Fuller GM. Detection of a complex that associates with the Bbeta fibrinogen G-455-A polymorphism. Blood 1998;92:3286–3293
   Google Scholar
• Martínez-Calatrava MJ, Martínez-Larrad MT, Zabena C, et al. The 4G/4G PAI-1 genotype is associated with elevated plasma PAI-1 levels regardless of variables of the metabolic syndrome and smoking status. A population-based study in Spanish population. Diabetes Obes Metab 2007;9:134–135
   Google Scholar
• Feng D, Lindpaintner K, Larson MG, et al. Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 1999;19:1142–1147
   PubMed Web of Science ®Google Scholar
• Margaglione M, Cappucci G, d’Addedda M, et al. PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants. Arterioscler Thromb Vasc Biol 1998;18:562–567
   PubMed Web of Science ®Google Scholar
• Von Depka M, Czwalinna A, Wermes C, et al. The deletion polymorphism in the angiotensin-converting enzyme gene is a moderate risk factor for venous thromboembolism. Thromb Haemost 2003;89:847–852
   Google Scholar
• Alhenc-Gelas M, Nicaud V, Gandrille S, et al. The factor V gene A4070G mutation and the risk of venous thrombosis. Thromb Haemost 1999;81:193–197
   Google Scholar
• Onrat ST, Emmiler M, Sivaci Y, et al. A patient with ascending aortic dilatation, similar to phenotypes of connective tissue disorders. Genet Mol Res 2009;8:426–434
   Google Scholar
• Patsopoulos NA, Analatos AA, Ioannidis JP. Relative citation impact of various study designs in the health sciences. JAMA 2005;293:2362–2366
   PubMed Web of Science ®Google Scholar
• Kavvoura FK, Ioannidis JP. Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls. Hum Genet 2008;123:1–14
   PubMed Web of Science ®Google Scholar
• Ioannidis JP, Patsopoulos NA, Evangelou E. Uncertainty in heterogeneity estimates in meta-analyses. BMJ 2007;335:914–916
   PubMed Web of Science ®Google Scholar
• Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 2006;25:3443–3457
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Wang P, Bell H, et al. Associations of thrombophilia, hypofibrinolysis, and retinal vein occlusion. Clin Appl Thromb Hemost 2005;11:375–389
   PubMed Web of Science ®Google Scholar
• Mattes D, Weger M, Renner W, et al. Role of angiotensin-converting enzyme insertion/deletion and plasminogen activator inhibitor-1 4G/5G gene polymorphisms in retinal vein occlusion. J Thromb Haemost 2005;3:2583–2584
   Google Scholar
• Albisinni R, Coppola A, Loffredo M, et al. Retinal vein occlusion and inherited conditions predisposing to thrombophilia. Thromb Haemost 1998;80:702–703
   Google Scholar
• Delahousse B, Arsène S, Piquemal R, et al. The 20 210A allele of the prothrombin gene is not a risk factor for retinal vein occlusion. Blood Coagul Fibrinolysis 1998;9:447–448
   Google Scholar
• Larsson J, Hillarp A. The prothrombin gene G20210A mutation and the platelet glycoprotein IIIa polymorphism PlA2 in patients with central retinal vein occlusion. Thromb Res 1999;96:323–327
   Google Scholar
• Kalayci D, Gürgey A, Güven D, et al. Factor V Leiden and prothrombin 20 210 A mutations in patients with central and branch retinal vein occlusion. Acta Ophthalmol Scand 1999;77:622–624
   PubMedGoogle Scholar
• Aras S, Yilmaz G, Alpas I, et al. Retinal vein occlusion and factor V Leiden and prothrombin 20 210 G: a mutations. Eur J Ophthalmol 2001;11:351–355
   Google Scholar
• Marcucci R, Bertini L, Giusti B, et al. Thrombophilic risk factors in patients with central retinal vein occlusion. Thromb Haemost 2001;86:772–776
   PubMed Web of Science ®Google Scholar
• Boyd S, Owens D, Gin T, et al. Plasma homocysteine, methylene tetrahydrofolate reductase C677T and factor II G20210A polymorphisms, factor VIII, and VWF in central retinal vein occlusion. Br J Ophthalmol 2001;85:1313–1315
   PubMed Web of Science ®Google Scholar
• Incorvaia C, Parmeggiani F, Costagliola C, et al. The heterozygous 20 210 G/A genotype prevalence in patients affected by central and branch retinal vein occlusion: a pilot study. Graefes Arch Clin Exp Ophthalmol 2001;239:251–256
   Google Scholar
• Margaglione M, Brancaccio V, Ciampa A, et al. Inherited thrombophilic risk factors in a large cohort of individuals referred to Italian thrombophilia centers: distinct roles in different clinical settings. Haematologica 2001;86:634–639
   Google Scholar
• Adamczuk YP, Iglesias Varela ML, Martinuzzo ME, et al. Central retinal vein occlusion and thrombophilia risk factors. Blood Coagul Fibrinolysis 2002;13:623–626
   PubMed Web of Science ®Google Scholar
• Marcucci R, Giusti B, Betti I, et al. Genetic determinants of fasting and post-methionine hyperhomocysteinemia in patients with retinal vein occlusion. Thromb Res 2003;110:7–12
   Google Scholar
• Dodson PM, Haynes J, Starczynski J, et al. The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion. Eye (Lond) 2003;17:772–777
   PubMed Web of Science ®Google Scholar
• Cruciani F, Moramarco A, Curto T, et al. MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion. Clin Ter 2003;154:299–303
   PubMedGoogle Scholar
• Arsène S, Delahousse B, Regina S, et al. Increased prevalence of factor V Leiden in patients with retinal vein occlusion and under 60 years of age. Thromb Haemost 2005;94:101–106
   PubMed Web of Science ®Google Scholar
• Weger M, Renner W, Steinbrugger I, et al. Role of thrombophilic gene polymorphisms in branch retinal vein occlusion. Ophthalmology 2005;112:1910–1915
   PubMed Web of Science ®Google Scholar
• Gumus K, Kadayifcilar S, Eldem B, et al. Is elevated level of soluble endothelial protein C receptor a new risk factor for retinal vein occlusion? Clin Experiment Ophthalmol 2006;34:305–311
   PubMed Web of Science ®Google Scholar
• Biancardi AL, Gadelha T, Borges WI, et al. Thrombophilic mutations and risk of retinal vein occlusion. Arq Bras Oftalmol 2007;70:971–974
   PubMedGoogle Scholar
• Di Capua M, Coppola A, Albisinni R, et al. Cardiovascular risk factors and outcome in patients with retinal vein occlusion. J Thromb Thrombolysis 2010;30:16–22
   Google Scholar
• Linna T, Ylikorkala A, Kontula K, et al. Prevalence of factor V Leiden in young adults with retinal vein occlusion. Thromb Haemost 1997;77:214–216
   PubMed Web of Science ®Google Scholar
• Ciardella AP, Yannuzzi LA, Freund KB, et al. Factor V Leiden, activated protein C resistance, and retinal vein occlusion. Retina 1998;18:308–315
   PubMedGoogle Scholar
• Demirci FY, Güney DB, Akarçay K, et al. Prevalence of factor V Leiden in patients with retinal vein occlusion. Acta Ophthalmol Scand 1999;77:631–633
   PubMedGoogle Scholar
• Johnson TM, El-Defrawy S, Hodge WG, et al. Prevalence of factor V Leiden and activated protein C resistance in central retinal vein occlusion. Retina 2001;21:161–166
   Web of Science ®Google Scholar
• Bombeli T, Basic A, Fehr J. Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems. Am J Hematol 2002;70:126–132
   Google Scholar
• Kuhli C, Hattenbach LO, Scharrer I, et al. High prevalence of resistance to APC in young patients with retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2002;240:163–168
   PubMed Web of Science ®Google Scholar
• Larsson J, Hultberg B, Hillarp A. Hyperhomocysteinemia and the MTHFR C677T mutation in central retinal vein occlusion. Acta Ophthalmol Scand 2000;78:340–343
   PubMedGoogle Scholar
• Cahill M, Karabatzaki M, Donoghue C, et al. Thermolabile MTHFR genotype and retinal vascular occlusive disease. Br J Ophthalmol 2001;85:88–90
   PubMed Web of Science ®Google Scholar
• Weger M, Stanger O, Deutschmann H, et al. Hyperhomocysteinemia and MTHFR C677T genotypes in patients with central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2002;240:286–290
   PubMed Web of Science ®Google Scholar
• Weger M, Stanger O, Deutschmann H, et al. Hyperhomocysteinemia, but not methylenetetrahydrofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusion. Ophthalmology 2002;109:1105–1109
   PubMedGoogle Scholar
• Di Crecchio L, Parodi MB, Sanguinetti G, et al. Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion. Ophthalmology 2004;111:940–945
   PubMedGoogle Scholar
• Ferrazzi P, Di Micco P, Quaglia I, et al. Homocysteine, MTHFR C677T gene polymorphism, folic acid and vitamin B 12 in patients with retinal vein occlusion. Thromb J 2005;7:3–13
   Google Scholar
• McGimpsey SJ, Woodside JV, Bamford L, et al. Retinal vein occlusion, homocysteine, and methylene tetrahydrofolate reductase genotype. Invest Ophthalmol Vis Sci 2005;46:4712–4716
   PubMed Web of Science ®Google Scholar
• Gao W, Wang YS, Zhang P, et al. MTHFR C677T mutation in central retinal vein occlusion: a case-control study in Chinese population. Thromb Res 2008;121:699–703
   PubMed Web of Science ®Google Scholar
• Sottilotta G, Siboni SM, Latella C, et al. Hyperhomocysteinemia and C677T MTHFR genotype in patients with retinal vein thrombosis. Clin Appl Thromb Hemost 2010;16:549–553
   PubMed Web of Science ®Google Scholar
• Cahill MT, Stinnett SS, Fekrat S. Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol 2003;136:1136–1150
   PubMed Web of Science ®Google Scholar
• McGimpsey SJ, Woodside JV, Cardwell C, et al. Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: a meta-analysis. Ophthalmology 2009;116:1778–1787
   PubMed Web of Science ®Google Scholar
• Said JM, Brennecke SP, Moses EK, et al. Ethnic differences in the prevalence of inherited thrombophilic polymorphisms in an asymptomatic Australian prenatal population. Hum Biol 2006;78:403–412
   Google Scholar
• Esfahani ST, Cogger EA, Caudill MA. Heterogeneity in the prevalence of methylenetetrahydrofolate reductase gene polymorphisms in women of different ethnic groups. J Am Diet Assoc 2003;103:200–207
   PubMed Web of Science ®Google Scholar
• Rehak M, Rehak J, Müller M, et al. The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis. Thromb Haemost 2008;99:925–929
   PubMed Web of Science ®Google Scholar
• Hayreh SS, Zimmerman B, McCarthy MJ, et al. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol 2001;131:61–77
   PubMed Web of Science ®Google Scholar
• Appiah AP, Trempe CL. Risk factors associated with branch vs. central retinal vein occlusion. Ann Ophthalmol 1989;21:153–155, 157
   PubMedGoogle Scholar
• Rosendaal FR, Doggen CJ, Zivelin A, et al. Geographic distribution of the 20 210 G to A prothrombin variant. Thromb Haemost 1998;79:706–708
   PubMed Web of Science ®Google Scholar
• Lucotte G, Mercier G. Population genetics of factor V Leiden in Europe. Blood Cells Mol Dis 2001;27:362–367
   PubMedGoogle Scholar
• Panagiotou OA, Ioannidis JP. Primary study authors of significant studies are more likely to believe that a strong association exists in a heterogeneous meta-analysis compared with methodologists. J Clin Epidemiol 2012;65:740–747
   Google Scholar
• Lasocki S, Iglarz M, Seince PF, et al. Involvement of renin-angiotensin system in pressure-flow relationship: role of angiotensin-converting enzyme gene polymorphism. Anesthesiology 2002;96:271–275
   Google Scholar
• Senchenkova EY, Russell J, Almeida-Paula LD, et al. Angiotensin II-mediated microvascular thrombosis. Hypertension 2010;56:1089–1095
   PubMed Web of Science ®Google Scholar
• Brown NJ, Vaughan DE. Prothrombotic effects of angiotensin. Adv Intern Med 2000;45:419–429
   PubMedGoogle Scholar
• Wells PS, Anderson JL, Scarvelis DK, et al. Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis. Am J Epidemiol 2006;164:101–109
   PubMed Web of Science ®Google Scholar
• Weger M, Renner W, Stanger O, et al. Role of factor XIII Val34Leu polymorphism in retinal artery occlusion. Stroke 2001;32:2759–2761
   Google Scholar
• Lim BC, Ariëns RA, Carter AM, et al. Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk. Lancet 2003;361:1424–1431
   PubMed Web of Science ®Google Scholar
• Vossen CY, Rosendaal FR. The protective effect of the factor XIII Val34Leu mutation on the risk of deep venous thrombosis is dependent on the fibrinogen level. J Thromb Haemost 2005;3:1102–1103
   PubMed Web of Science ®Google Scholar
• Larsson J, Hillarp A. The prothrombin gene G20210A mutation and the platelet glycoprotein IIIa polymorphism PlA2 in patients with central retinal vein occlusion. Thromb Res 1999;96:323–327
   Google Scholar
• Salomon O, Moisseiev J, Vilganski T, et al. Role of five platelet membrane glycoprotein polymorphisms in branch retinal vein occlusion. Blood Coagul Fibrinolysis 2006;17:485–488
   Google Scholar
• Panagiotou OA, Evangelou E, Ioannidis JP. Genome-wide significant associations for variants with minor allele frequency of 5% or less – an overview: a HuGE review. Am J Epidemiol 2010;172:869–889
   PubMed Web of Science ®Google Scholar
• McCarthy MI, Abecasis GR, Cardon LR, et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 2008;9:356–369
   PubMed Web of Science ®Google Scholar
• Hindorff LA, Sethupathy P, Junkins HA, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009;106:9362–9367
   PubMed Web of Science ®Google Scholar